Cumulative cisplatin dose in concurrent chemoradiotherapy for head and neck cancer: A systematic review-Reference-Cited by-同舟云学术

Cumulative cisplatin dose in concurrent chemoradiotherapy for head and neck cancer: A systematic review

Published:2015-07-14 Issue:S1 Volume:38 Page:E2151-E2158
ISSN:1043-3074
Container-title:Head & Neck
language:en
Short-container-title:Head Neck

Author:

Strojan Primož¹,Vermorken Jan B.²,Beitler Jonathan J.³,Saba Nabil F.⁴,Haigentz Missak⁵,Bossi Paolo⁶,Worden Francis P.⁷,Langendijk Johannes A.⁸,Eisbruch Avraham⁹,Mendenhall William M.¹⁰,Lee Anne W. M.¹¹,Harrison Louis B.¹²,Bradford Carol R.¹³,Smee Robert¹⁴,Silver Carl E.¹⁵,Rinaldo Alessandra¹⁶,Ferlito Alfio¹⁶

Affiliation:

1. Department of Radiation Oncology; Institute of Oncology; Ljubljana Slovenia

2. Department of Medical Oncology; Antwerp University Hospital; Edegem Belgium

3. Departments of Radiation Oncology, Otolaryngology, and Medical Oncology; Emory University School of Medicine; Atlanta Georgia

4. Department of Hematology and Medical Oncology; The Winship Cancer Institute of Emory University; Atlanta Georgia

5. Department of Medicine, Division of Oncology; Albert Einstein College of Medicine, Montefiore Medical Center; Bronx, New York

6. Fondazione IRCCS Istituto Nazionale dei Tumori; Milan Italy

7. Department of Internal Medicine; University of Michigan Comprehensive Cancer Center; Ann Arbor Michigan

8. Department of Radiation Oncology; University Medical Center Groningen, University of Groningen; Groningen The Netherlands

9. Department of Radiation Oncology; University of Michigan; Ann Arbor Michigan

10. Department of Radiation Oncology; University of Florida; Gainesville Florida

11. Center of Clinical Oncology; University of Hong Kong - Shenzhen Hospital; Shenzhen China

12. Department of Radiation Oncology; Beth Israel Medical Center and St Luke's-Roosevelt Hospitals, New York; New York

13. Department of Otolaryngology-Head and Neck Surgery; University of Michigan; Ann Arbor Michigan

14. Department of Radiation Oncology; The Prince of Wales Cancer Centre; Sydney New South Wales Australia

15. Departments of Surgery and Otolaryngology-Head and Neck Surgery; Albert Einstein College of Medicine, Montefiore Medical Center; Bronx, New York

16. University of Udine School of Medicine; Udine Italy

Publisher

Wiley

Subject

Otorhinolaryngology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hed.24026/fullpdf

Reference52 articles.

1. EHNS-ESMO-ESTRO Guidelines Working Group. Squamous cell carcinoma of the head and neck: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Grégoire;Ann Oncol,2010

2. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data;Pignon;Lancet,2000

3. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients;Pignon;Radiother Oncol,2009

4. Head and neck carcinoma in the United States: first comprehensive report of the Longitudinal Oncology Registry of Head and Neck Carcinoma (LORHAN);Ang;Cancer,2012

5. http://www.nccn.org/professionals/physician_gls/f_guidelines.asp 2014

Cited by 163 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Feasibility of weekly cisplatin and radiotherapy for localized anal cancer – A Danish anal cancer group report;Radiotherapy and Oncology;2024-10

2. Treatment-related hearing loss in weekly versus triweekly cisplatin chemoradiation for head and neck cancer;European Archives of Oto-Rhino-Laryngology;2024-09-06

3. The association between skeletal muscle mass and sensorineural hearing loss upon cisplatin‐based chemoradiotherapy in patients with head and neck squamous cell carcinoma;Head & Neck;2024-08-02

4. Standard versus fractionated high-dose cisplatin plus radiation for locally advanced head and neck cancer: Results of the CisFRad (GORTEC 2015-02) randomized phase II trial;Radiotherapy and Oncology;2024-08

5. Kopf-Hals-Onkologie des älteren Patienten;Die MKG-Chirurgie;2024-07-30